Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases

Clinical trial NCT03754140 · WITHDRAWN

Trial details

NCT number: NCT03754140
Sponsor: Melanoma Institute Australia
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma In-Transit Metastasis of Cutaneous Melanoma

Start date: 2020-05-20
Primary completion: 2022-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.